PSA
Prostate-specific antigen, a blood test used to screen for prostate cancer that produces many false positives
As defined in Eric Topol on the Creative Destruction of Medicine
Where it comes up · 7
- Robert Aronowitz on Risky Medicine3 claims
- Adam Cifu on the Case for Being a Medical Conservative2 claims
- Azra Raza on The First Cell2 claims
- How to Be a Super Ager (with Eric Topol)1 claim
- Eric Topol on the Creative Destruction of Medicine1 claim
- Peter Attia on Lifespan, Healthspan, and Outlive1 claim
- 77 | Azra Raza on The Way We Should Fight Cancer1 claim
Most important claims · 10 of 11Search all claims for “PSA” →
- Cancer mortality has dropped about 26% over the last 30 years not because of any new magic-bullet drug but because of two things: anti-smoking campaigns and four decades-old screening measures (mammography, colonoscopy, pap smear, PSA)—and these have now been milked dry, with mortality currently declining only ~1% a year from better use of existing therapies and earlier imaging.77 | Azra Raza on The Way We Should Fight Cancer
- PSA testing diffused widely across American society and the world starting around 1989, yet the first results of randomized clinical trials of PSA screening only appeared in 2009—roughly 20 years later—showing that the mass phenomenon developed its own social and psychological inertia long before any scientific evidence existed.Robert Aronowitz on Risky Medicine
- Medical conservatives resist conflating a therapy's benefit to a population with its benefit to an individual; many screening tests like prostate screening and mammography deliver shockingly small or zero benefit while generating enormous numbers of false positives that alarm patients and lead to dangerous downstream tests and treatments.Adam Cifu on the Case for Being a Medical Conservative
- Universal recommendations that all men get a PSA or all women get a mammogram induce net harm at the population level: roughly 250,000 US men per year have a false-positive PSA leading to repeated painful biopsies and emotional hardship without cancer, and mammography data show an overall lack of benefit; these harms outweigh the few people detected early, so blanket screening should be replaced by individualized risk-based strategies.Eric Topol on the Creative Destruction of Medicine
- Population-wide screening rules like the Preventive Task Force's recommendation against PSA testing are mistaken because they treat all humans identically ('like cattle'); the better approach is to use polygenic risk scores to identify high-risk individuals (such as President Biden's prostate cancer) who warrant intensive personalized surveillance.How to Be a Super Ager (with Eric Topol)
- Many widely promoted screening techniques—colonoscopy, mammograms, PSA tests—have led to more harm than good, with false positives, the test itself, and the anguish and damage often worse than the disease, producing a net effect on mortality that is frequently zero or negative; so most of the time, under current technology, it is better not to look.Azra Raza on The First Cell
- PSA screening of asymptomatic men frequently detects low-grade cancers that may never cause harm, committing the man to a lifetime of surveillance (repeat PSA tests, biopsies, ultrasounds) that itself creates a chronic state of bodily risk and anxiety—a Sword of Damocles—such that many men choose prostatectomy not to live longer but to rid themselves of the unbearable state of uncertainty.Robert Aronowitz on Risky Medicine
- The European PSA screening trial's number-needed-to-treat figure was that about 50 men had to be treated for prostate cancer (with thousands screened to find them) to avert a single death, and given the high rates of incontinence, impotence, blood clots, and incidental hospital deaths from surgery, the speaker judges those 50-to-1 odds not worth it for himself.Robert Aronowitz on Risky Medicine
- We have known since 1907 that it is not cancer itself that kills but the delay in treatment, so the earlier the disease is detected the better—yet we still rely on 50-year-old detection methods (PSA, mammograms, scopes) despite supreme technological advances elsewhere.Azra Raza on The First Cell
- Prostate cancer screening produces a mix of outcomes: some patients have aggressive tumors caught early and possibly lives saved, others undergo therapy they later regret as life-worsening, and still others are made anxious by information they never needed—and the people paying the costs of screening are different from those who benefit.Adam Cifu on the Case for Being a Medical Conservative